SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Directorate Change

22 Jul 2014 07:00

RNS Number : 9198M
Rentokil Initial PLC
22 July 2014
 



 

22 July 2014

 

 

APPOINTMENT OF NON-EXECUTIVE DIRECTOR

 

Rentokil Initial plc (FTSE: RTO) today announces the appointment of Julie Southern to its Board as a Non-Executive Director with effect from 21 July 2014. Julie will also become Chair of the Audit Committee on her appointment to the Board.

 

Julie Southern has extensive financial and commercial experience working in international markets. Most recently she was Chief Commercial Officer of Virgin Atlantic Limited between 2010 and 2013, responsible for the commercial strategy of Virgin Atlantic Airways and Virgin Holidays. Prior to this, Julie was Chief Financial Officer of Virgin Atlantic Limited for 10 years from 2000 to 2010. She has also held a number of additional senior financial roles including Group Finance Director at Porsche Cars Great Britain and Finance and Operations Director at HJ Chapman & Co. She is currently a Non-Executive Director and member of the Audit Committee for NXP Semi-Conductors N.V. (NASDAQ: NXPI) and a chartered accountant, having begun her career at Price Waterhouse.

 

As previously announced, Duncan Tatton-Brown, Chair of the Audit Committee, retired after serving nine years on the Board, following Rentokil Initial's AGM earlier this year.

 

Commenting on the appointment, John McAdam, Chairman of Rentokil Initial, said:

 

"We are delighted to welcome Julie to the Board. She is an experienced professional, having worked with some of the world's best known brands, and will bring valuable international business insight to the Board. We wish her well in her new role."

 

In accordance with Listing Rule 9.6.15, it is confirmed that there are no other details to be disclosed pursuant to Listing Rule 9.6.13.

 

Ends

 

 

Media enquiries:

 

Malcolm Padley Rentokil Initial plc 07788 978199

Justine McIlroy / Nina Coad Brunswick Group 020 7404 5959

 

About Rentokil Initial plc:

 

Rentokil Initial is one of the largest business services companies in the world, providing pest control, hygiene and workwear services. It has some 27,000 employees and operates in almost 70 countries.

 

http://www.rentokil-initial.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPGUMCMUPCGQG
Date   Source Headline
21st May 20267:00 amRNSAppointment of CEO, North America
8th May 202610:30 amRNSHolding(s) in Company
7th May 20264:40 pmRNSResult of AGM
23rd Apr 20264:25 pmRNSFinal Dividend – Pence Sterling Amount Payable
23rd Apr 20262:30 pmRNSIssuance of $500 million 4.625% Notes due 2031
21st Apr 202610:30 amRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ1 Trading Update
15th Apr 20267:00 amRNSDirectorate Change
30th Mar 202610:30 amRNSHolding(s) in Company
26th Mar 20263:46 pmRNSDirector/PDMR Shareholding
25th Mar 202610:50 amRNSAnnual Financial Report
17th Mar 20264:30 pmRNSDirector/PDMR Shareholding
16th Mar 202610:32 amRNSHolding(s) in Company
16th Mar 202610:32 amRNSHolding(s) in Company
12th Mar 202610:30 amRNSHolding(s) in Company
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
9th Mar 202611:15 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSPreliminary Results
5th Mar 20267:00 amRNSChair Succession Planning Update
23rd Feb 202610:30 amRNSHolding(s) in Company
19th Feb 20262:50 pmRNSDirector Declaration
12th Feb 20265:30 pmRNSNotice of Early Redemption
20th Jan 202610:25 amRNSHolding(s) in Company
19th Jan 202610:30 amRNSHolding(s) in Company
16th Jan 20263:00 pmRNSHolding(s) in Company
14th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 20267:00 amRNSDirectorate change
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
5th Dec 202510:30 amRNSHolding(s) in Company
5th Dec 202510:30 amRNSHolding(s) in Company
26th Nov 20254:25 pmRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
27th Oct 202510:30 amRNSHolding(s) in Company
23rd Oct 202511:45 amRNSHolding(s) in Company
23rd Oct 20257:00 amRNSQ3 Trading Update
21st Oct 202510:00 amRNSHolding(s) in Company
14th Oct 202510:00 amRNSHolding(s) in Company
1st Oct 202510:30 amRNSBlock listing Interim Review
30th Sep 202510:30 amRNSCompletion of France Workwear business sale
25th Sep 20254:15 pmRNSDirector/PDMR Shareholding
24th Sep 20256:00 pmRNSDirector Declaration
26th Aug 202512:30 pmRNSInterim Dividend – Pence Sterling Amount Payable
7th Aug 202511:10 amRNSHolding(s) in Company
31st Jul 20257:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.